1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient characteristics
Characteristic Value Sex Male 85/186 (45%) Female 101/186 (54%) Overall age (range) (yr) 54.8 (18–88) Underlying etiology Tumor 12/186 (6%) Posthemorrhagic hydrocephalus 59/186 (31%) Congenital hydrocephalus 16/186 (8%) Postinfectious hydrocephalus 5/186 (2%) Posttraumatic hydrocephalus 12/186 (6%) Posterior fossa cyst 2/186 (1%) Idiopathic intracranial hypertension 23/186 (12%) Normal-pressure hydrocephalus 40/186 (46%) Aqueduct stenosis 17/186 (9%) Symptoms Yes Headache 33/186 (17%) Nausea and vomiting 9/186 (4%) Fatigue 19/186 (10%) Gait disturbance 34/186 (18%) Others 36/186 (19%) Multiple 5/186 (2%) No 50/186 (26%) Clinical indication 24 Hours after implantation 102/186 (54%) Complication suspected 84/186 (45%) Secondary findings Dystelectasis 7/186 (3%) Pneumonia 2/186 (1%) Pleural effusion 6/186 (3%) Nephrolithiasis 1/186 (0,5%) Incidental tumor findings 1/186 (0,5%) Abdominal aortic aneurysm 1/186 (0,5%)